Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 20 results for "zenotech laboratories"

Zenotech Laboratories informs about Board Meeting

SENSEX 27687.30 363.30 1.33% NIFTY 8373.65 111.30 Finalaya.com, 1 week ago
India Infoline

Zenotech Laboratories stock ends 5% upper limit

Zenotech Laboratories was locked at the 5% upper limit at Rs. 45.25 after Sun Pharma made an open offer to buy 9.7 million shares at Rs. 20.87 pursuant to the Ranbaxy merger deal. Zenotech Laboratories was locked at the 5% upper limit at Rs. 45.25 after Sun ...
 India Infoline1 month ago

Zenotech rises to upper limit on Sun Pharma's open offer

Zenotech Laboratories touched its 52-week high in trade today, with the scrip hitting an upper circuit limit of 5 per cent in a reaction to Sun Pharmaceutical Industries' open offer to acquire nearly 9.7 mn shares in the company at Rs 20.87 per share. A ...
 Economic Times1 month ago Zenotech hits upper circuit on Sun's open offer  Economic Times1 month ago

Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2015-2025

/PRNewswire/ -- Biosimilar drug producers - your guide to those companies' activities and prospects What does the future hold for makers of biosimilar medicines? Discover those companies' outlooks from 2015. You see results, trends, opportunities ...
 TickerTech.com1 month ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less